BG Medicine (BGMD) Tops Q4 EPS by 1c

BG Medicine (NASDAQ: BGMD) reported Q4 EPS of ($0.04), $0.01 better than the analyst estimate of ($0.05).

For earnings history and earnings-related data on BG Medicine (BGMD) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Jefferies Downgrades Pop Mart International Group Ltd (9992:HK) to Hold
• Goldman Sachs Downgrades Shanghai Jahwa United (600315:CH) to Neutral